IP Library › Granted Patent US 10,118,933
Granted Patent B2
US 10,118,933 · App. 15/486,995 · Granted Nov 6, 2018

Androgen receptor modulating compounds

Inventors: Gerd Wohlfahrt (Helsinki, FI); Olli Törmäkangas (Turku, FI); Harri Salo (Turku, FI); Iisa Höglund (Turku, FI); Arja Karjalainen (Espoo, FI); Pia Koivikko (Littoinen, FI); Patrik Holm (Lielahti TL, FI); Sirpa Rasku (Vantaa, FI); Anniina Vesalainen (Paimio, FI)
Assignee: ORION CORPORATION
C07D513/04C07D231/12C07D231/14C07D401/12C07D401/14C07D403/12C07D405/12C07D405/14C07D409/14C07D413/12C07D413/14C07D417/12C07D417/14C07D471/04C07D487/04C07D498/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,118,933
App. No.
15/486,995
Granted
Nov 6, 2018
Kind
B2
Abstract

The present disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts thereof. The present disclosure also relates to compositions and methods of treating comprising compounds of formula (I), and pharmaceutically acceptable salts thereof.

Claims (5)

1. A compound, which is

2-chloro-4-(1H-pyrazol-5-yl)benzonitrile or

(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile.

2. The compound according to claim 1 , which is 2-chloro-4-(1H-pyrazol-5-yl)benzonitrile.

3. The compound according to claim 1 , which is (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile.

Continuity (4)
Continuation 14598973 · Jan 16, 2015
Continuation 13504511
Provisional Application 61255159 · Oct 27, 2009
Related Publication 20170260206A1 · Sep 14, 2017
Cited By (1)
US 12,496,301